Spruce Biosciences (SPRB)
(Delayed Data from NSDQ)
$0.70 USD
-0.03 (-3.87%)
Updated May 24, 2024 04:00 PM ET
After-Market: $0.70 0.00 (0.36%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/12/2024
Time: -- |
6/2024 | $-0.33 | -5.61% |
Earnings Summary
For their last quarter, Spruce Biosciences (SPRB) reported earnings of -$0.28 per share, beating the Zacks Consensus Estimate of $-0.32 per share. This reflects a positive earnings surprise of 12.50%. Look out for SPRB's next earnings release expected on August 12, 2024. For the next earning release, we expect the company to report earnings of -$0.33 per share, reflecting a year-over-year decrease of 3.13%.
Earnings History
Price & Consensus
Zacks News for SPRB
Pfizer (PFE) Q1 Earnings and Revenues Beat Estimates
SPRB: What are Zacks experts saying now?
Zacks Private Portfolio Services